LDXHF OTC
Lumos Diagnostics Holdings Ltd.
1W: -11.9%
1M: -15.5%
3M: -12.5%
YTD: -65.7%
1Y: -39.1%
3Y: -5.4%
5Y: -90.3%
$0.07
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$66.1M
52W Range0.0576-0.24
Volume34,400
Avg Volume28,169
Beta0.55
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODouglas Ward
Employees15
SectorHealthcare
IndustryMedical - Specialties
IPO Date2021-09-22
Websitelumosdiagnostics.com
2724 Loker Ave West
Carlsbad, CA 92010
US
Carlsbad, CA 92010
US
61 3 9087 1598
About Lumos Diagnostics Holdings Ltd.
Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company's products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. Lumos Diagnostics Holdings Limited was incorporated in 2018 and is based in Carlsbad, California.
Recent Insider Trades
No insider trades found